HIMS
Price
$27.51
Change
+$0.07 (+0.26%)
Updated
Sep 11 closing price
Capitalization
6.42B
58 days until earnings call
Intraday BUY SELL Signals
HIMZ
Price
$24.18
Change
+$0.07 (+0.29%)
Updated
Sep 11 closing price
Net Assets
57.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

HIMS vs HIMZ

HIMS vs HIMZ Comparison Chart in %
View a ticker or compare two or three
VS
HIMS vs. HIMZ commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Hold and HIMZ is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
HIMS: Fundamental Ratings
HIMS
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HIMSHIMZ
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
86%
Bullish Trend 23 days ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (HIMS: $27.51)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIMS’s FA Score shows that 0 FA rating(s) are green while .

  • HIMS’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIMS’s TA Score shows that 2 TA indicator(s) are bullish.

  • HIMS’s TA Score: 2 bullish, 5 bearish.

Price Growth

HIMS (@Pharmaceuticals: Generic) experienced а -0.72% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

HIMS is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
HIMZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNBK0.980.03
+2.82%
Patriot National Bancorp
MITQ0.600.01
+1.73%
Moving iMage Technologies
FWRG11.350.16
+1.43%
First Watch Restaurant Group
IOT38.38-0.06
-0.16%
Samsara
CURB29.32-0.08
-0.27%
Curbline Properties Corp

HIMS and

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
+0.26%
COTY - HIMS
31%
Poorly correlated
+2.66%
EVO - HIMS
24%
Poorly correlated
-2.26%
IPAR - HIMS
24%
Poorly correlated
+1.38%
IRWD - HIMS
24%
Poorly correlated
+2.77%
AQST - HIMS
23%
Poorly correlated
-4.21%
More

HIMZ and

Correlation & Price change

A.I.dvisor tells us that HIMZ and HIMS have been poorly correlated (+-5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMZ and HIMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMZ
1D Price
Change %
HIMZ100%
+0.29%
HIMS - HIMZ
-5%
Poorly correlated
+0.26%